参考文献/References:
[1].Abate M,Festa A,Falco M,et al. Mitochondria as playmakers of apoptosis,autophagy and senescence[J]. Semin Cell Dev Biol,2019,?pii:S1084-9521(18)30187-3.
[2].Rosca MG,Tandler B,Hoppel CL. Mitochondria in cardiac hypertrophy and heart failure[J]. J Mol Cell Cardiol,2013,55:31-41
[3].Wai T,Langer T. Mitochondrial dynamics and metabolic regulation[J]. Trends Endocrinol Metab,2016,27(2):105-117.
[4].Leonardo AM. Energy metabolism in cardiac remodeling and heart failure[J]. Cardiol Rev,
[5].2013 ,21(3):135-140.
[6].Fragasso G,Salerno A,Lattuada G,et al. Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure[J]. Heart,2011,97(18):1495-1500.
[7].Jain A,Atale N,Kohli S,et al. An assessment of norepinephrine mediated hypertrophy to apoptosis transition in cardiac cells:a signal for cell death[J]. Chem Biol Interact,2015,225:54-62.
[8].Bertero E,Maack C. Calcium Signaling and Reactive Oxygen Species in Mitochondria[J]. Circ Res,2018,122(10):1460-1478.
[9].Deshwal S,Di Sante M,Di Lisa F,et al. Emerging role of monoamine oxidase as a therapeutic target for cardiovascular disease[J]. Curr Opin Pharmacol,2017,33:64-69.
[10].Lebrecht D,Kokkori A,Ketelsen UP,et al. Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin[J]. J Pathol,2005,207:436-444.
[11].Miyata N,Goda N,Matsuo K. Cooperative function of Fmp30,Mdm31,and Mdm32 in Ups1-independent cardiolipin accumulation in the yeast Saccharomyces cerevisiae[J]. Sci Rep,2017,7(1):16447.
[12].Kameoka S,Adachi Y,Okamoto K,et al. Phosphatidic acid and cardiolipin coordinate mitochondrial dynamics[J]. Trends Cell Biol,2018,28(1):67-76.
[13].Zhang Y,Guallar E,Ashar FN,et al. Association between mitochondrial DNA copy number and sudden cardiac death:findings from the Atherosclerosis Risk in Communities study (ARIC)[J]. Eur Heart J,2017,38(46):3443-3448.
[14].Chen Y,Liu Y,Gerald W. Dorn. Mitochondrial fusion is essential for organelle function and
[15].cardiac homeostasis[J]. Circ Res,2011,109(12):1327-1331.
[16].Bernhardt D,Müller M,Reichert AS,et al. Simultaneous impairment of mitochondrial fission and fusion reduces mitophagy and shortens replicative lifespan[J]. Sci Rep,2015,5:7885.
[17].Yang H,Shen H,Li J,et al. SIGMAR1/Sigma-1 receptor ablation impairs autophagosome clearance.[J]. Autophagy,2019,15(9):1539-1557.
[18].Huang CY,Lai CH,Kuo CH,et al. Inhibition of ERK-Drp1 signaling and mitochondria fragmen-tation alleviates IGF-IIR-induced mitochondria dysfunction during heart failure[J]. J Mol Cell Cardiol,2018,122:58-68.
[19].Sato T,Kadowaki A,Suzuki T,et al. Loss of Apelin Augments AngiotensinⅡ-Induced Cardiac Dysfunction and Pathological Remodeling[J]. Int J Mol Sci,2019,20(2).?pii: E239.
[20].Tian HP,Sun YH,He L,et al. Single-stranded DNA-binding protein 1 abrogates cardiac fibro-blast proliferation and collagen expression induced by angiotensinⅡ[J]. Int Heart J.2018,59(6):1398-1408.
[21].Kumar S,Wang G,Zheng N,et al. HIMF(hypoxia-induced mitogenic factor)-IL(interleukin)-6 signaling mediates cardiomyocyte-fibroblast crosstalk to promote cardiac hypertrophy and fi-
[22].brosis[J]. Hypertension,2019,73(5):1058-1070.
[23].Umbarawan Y,Syamsunarno MRAA,Koitabashi N,et al. Myocardial fatty acid uptake through CD36 is indispensable for sufficient bioenergetic metabolism to prevent progression of pressure overload-induced heart failure[J]. Sci Rep.2018,8(1):12035.
[24].Kalpage HA,Bazylianska V,Recanati MA,et al. Tissue-specific regulation of cytochrome c by post-translational modifications:respiration,the mitochondrial membrane potential,ROS,and apoptosis[J]. FASEB J,2019,33(2):1540-1553.
[25].Quryshi N,Norwood Toro LE,Ait-Aissa K,et al. Chemotherapeutic-induced cardiovascular dysfunction:physiological effects,early detection—the role of telomerase to counteract mitochondrial defects and oxidative stress[J]. Int J Mol Sci,2018,19(3).pii: E797.
[26].Anderson R,Lagnado A,Maggiorani D.Maggiorani,Damien,et al, Length-independent telomere damage drives post-mitotic cardiomyocyte senescence[J]. EMBO J,2019,38(5).pii: e100492.
[27].Hafner AV,Dai J,Gomes AP,et al. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy[J]. Aging (Albany NY),2010,2(12):914-923.
[28].Karbowska J,Kochan Z,Smoleński,et al. Peroxisome proliferator-activated receptor alpha is
[29].downregulated in the failing human heart[J]. Cell Mol Biol Lett,2003,8(1):49-53.
[30].Jia G,Hill MA,Sowers JR. Diabetic Cardiomyopathy:An Update of Mechanisms Contributing to This Clinical Entity[J]. Circ Res.2018,122(4):624-638.
[31].Chen P,Zhan Q,Bai Y,et al. Serum Peroxisome proliferator-activated receptor gamma coact-ivator-1α related to myocardial energy expenditure in patients with chronic heart failure[J].
[32].Am J Med Sci,2019,357(3):205-212.
[33].Leucker TM,Bienengraeber M,Muravyeva M,et al. Endothelial-cardiomyocyte crosstalk enhances pharmacological cardioprotection[J]. Mol Cell Cardiol,2011,51(5):803-811.
[34].Matsuhashi T,Sato T,Kanno SI,et al. Mitochonic acid 5(MA-5) facilitates ATP synthase oligomerization and cell survival in various mitochondrial diseases[J]. EBioMedicine,2017,20:27-38.
[35].Sharma A,Stevens SR,Lucas J,et al. Utility of growth differentiation factor-15,a?marker of oxidative stress and inflammation,in chronic heart failure:insights from the HF-ACTION study[J]. JACC Heart Fail,2017,5(10):724-734.
[36].Yatsuga S,Fujita Y,Ishii A,et al. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders[J]. Ann Neurol,2015,78(5):814-823.
相似文献/References:
[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(1):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(1):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(1):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(1):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on
Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(1):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[7]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(1):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[8]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(1):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[9]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(1):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
[10]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(1):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]